Skip to main content

Rising prevalence of colorectal cancer and other endoscopy-related diseases to boost the growth of endoscope reprocessing device market.

 


Market Overview:

Endoscope reprocessing devices are those which are made to kill the organisms in the reusable endoscopes using high disinfectants or liquid chemical solutions to expose the exterior surfaces and the interior channels. Manual cleaning, sterilization, documentation, leak testing and pre –cleaning are some of the steps performed in endoscopy reprocessing.

Competitive Landscape:

The major players operating the endoscope reprocessing device market are STERIS Plc., Cilag GmbH International, Steelco S.p.A., Minntech Corp PENTAX Medical, Medivators Inc., Wassenburg Medical B.V., Soluscope, ENDO-TECHNIK W.Griesat GmbH, Johnson & Johnson and Getinge AB. 

Key Market Drivers:

Rising prevalence of colorectal cancer and other endoscopy-related diseases are anticipated to augment the growth of the global endoscope reprocessing device market. For instance, as per the American Cancer Society, nearly 97,220 people are diagnosed with colorectal cancer and 43,030 rectal cancer by the end of 2018.

Furthermore, increasing cardiovascular diseases which are treated with using ERs is anticipated to boost the growth of the global endoscope reprocessing device market. For instance, as per OECD, 45,307 people have undergone the coronary heart bypass surgery/operation in Germany as of 2018. 

Covid-19 Impact Analysis:

During the pandemic, along with the sterilization the ERs have also increased as the reprocessors have been a crucial part for the endoscopy surgeries which led to the growth of the global endoscope reprocessing device market.

Key Takeaways:

The global endoscope reprocessing device market is expected to exhibit a CAGR of XX % during the forecast period due to frequent approvals, quick launches of products. For instance, in April 2019, Advanced Sterilization Products gained US. FDA, launched for the ASP AEROFLEX automated endoscopes reprocessors.

Among Regions North America, Asia Pacific and Europe are anticipated to witness robust growth in the global endoscope reprocessing device market due to increasing prevalence of diseases, frequent approvals. As per the Globocan, 3,244 people suffer from stomach cancer in Canada and 5,139 people suffer from pancreatic cancer.

 

 

Comments

Popular posts from this blog

Life Sciences BPO Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

  The growing cost of drug development is augmenting the growth of the global life sciences BPO market. For instance, according to a study by the Tufts Center for the Study of Drug Development published in the Journal of Health Economics in May 2019, the cost of drug development was US$ 2.6 billion, which included average out-of-pocket costs of US$ 1.4 billion and time costs of US$ 1.2 billion. Also, patent expiration is another key factor propelling the growth of the life sciences BPO market. For instance, the patent for YAZ (drospirenone/ethinylestradiol), which provides an oral contraceptive regimen, is set to expire in 2021. Furthermore, the rising prevalence of chronic disease around the globe is further anticipated to accelerate the growth of the market. North America is projected to lead the global life sciences BPO market due to increasing R&D in cell therapies by key players in the region. For instance, in February 2020, Caribou Biosciences, Inc., a CRISPR genome editin

Structural Heart Devices Market to develop innovative Mitral Valve Repair Technology

  Structural heart devices Market are medical devices with the ability to pump blood by way of the heart. This device is called the ventricular myocardium, and it is what pumps blood from the heart to the various chambers of the body. The structure that this type of heart device has is very basic - a couple of stacks of cells (or more, depending upon the desired function), and a tubing filled with fluid that can allow for the movement of the cells. This particular construction has allowed these devices to be built so that they can pump blood and create heart attacks and heart failure with much greater efficiency. Lack of skilled personnel and low affordability is expected to restrain growth of the global structural heart devices market during the forecast period. However, the emergence of tissue-engineered heart valves and the advent of percutaneous interventions can offer major business opportunities in the global structural heart devicesmarket . Key players involved in the global

Mixed Reality in Healthcare Market 2022 Global Industry Analysis By Size, Share, Trends and Growth Till 2028

  Mixed Reality technologies help in improving the productivity of healthcare professionals. They are able to work more productively as they are allowed to fully enjoy all the benefits of both worlds. The main use of augmented reality or virtual reality in this regard is related to the treatment and rehabilitation of patients in a medical environment. There are many pharmaceutical companies that are using the technologies to manufacture better medicines and better equipment. Mixed Reality in Healthcare Market - Market Dynamics Growing demand for digitalization in healthcare sector is a major factor contributing to significant growth of mixed reality in healthcare market . Moreover, the market is expected to witness positive growth with rising prevalence of neurological & psychological disorders across the world.